Sickle Cell Patients, Families And Doctors Face A ‘Fight For Everything’
(By Jenny Gold for Kaiser Health News) CHICAGO — The day before his 30th birthday, Marqus Valentine was in a
Read More
Part D/Prescription Drugs
FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs
(By Sarah Jane Tribble for Kaiser Health News) The commissioner of the Food and Drug Administration questions whether the right
Read MoreArthritis Drugs Show How U.S. Drug Prices Defy Economics
(By Julie Appleby for Kaiser Health News) Renda Bower knows well the cost of drugs to treat rheumatoid arthritis –
Read MoreFDA approves first gene therapy targeting rare form of inherited blindness
(By Adam Feuerstein for STAT) A first-of-its-kind gene therapy received approval from the Food and Drug Administration on Tuesday to
Read MoreDrug Industry Spent Millions To Squelch Talk About High Drug Prices
(By Jay Hancock for Kaiser Health News) Facing bipartisan hostility over high drug prices in an election year, the pharma
Read MorePressure builds on the DEA to stem the supply of prescription drugs, but at what cost?
(By Lev Facher for STAT) WASHINGTON — In a bland Northern Virginia office building nestled between a Costco and a
Read MorePharmacy Costs Continue To Soar For California’s Public Employee Health System
(By Pauline Bartolone for California Healthline produced by Kaiser Health News) Spending on prescription drugs by the California Public Employees’
Read MoreAetna to waive copays for opioid overdose antidote Narcan: 3 things to know
(By Morgan Haefner for Becker’s Hospital Review) Aetna will waive copays for Narcan, a brand-name drug used to reverse opioid overdose, for
Read MoreTelemedicine For Addiction Treatment? Picture Remains Fuzzy
(By Emily Forman, Side Effects Public Media in partnership with NPR and Kaiser Health News) When President Donald Trump declared
Read MoreCMS investigate whether the Part D formulary and benefit offerings are being administered as approved
The Centers for Medicare & Medicaid Services may hire a contractor to track whether the companies that sell Medicare Part
Read More